Treatment of recurrent HCV infection following liver transplantation: Results of a multicenter, randomized, versus placebo, trial of ribavirin alone as maintenance therapy after one year of PegIFNα-2a plus ribavirin

Journal of Hepatology

Volumn 57, Issue 3, 2012, Pages 564-571

  Calmus, Yvon ^a,m   Duvoux, Christophe ^b   Pageaux, Georges ^c   Wolf, Philippe ^d   Rostaing, Lionel ^e   Vanlemmens, Claire ^f   Botta Fridlund, Danielle ^g   Dharancy, Sébastien ^h   Gugenheim, Jean ⁱ   Durand, Franois ^j   Néau Cransac, Martine ^k   Boillot, Olivier ^l   Chazouillres, Olivier ^m   Samelson, Laurence ⁿ   Boudjema, Karim ^o   Samuel, Didier ^p  

^a Institut Cochin   (France)

^b HENRI MONDOR HOSPITAL   (France)

^c HÔPITAL SAINT ELOI   (France)

^d HÔPITAL DE HAUTEPIERRE   (France)

^e CHU RANGUEIL   (France)

^f UNIVERSITY HOSPITAL JEAN MINJOZ   (France)

^g HÔPITAL DE LA CONCEPTION   (France)

^h LILLE UNIVERSITY HOSPITAL   (France)

ⁱ CENTRE HOSPITALIER UNIVERSITAIRE DE NICE   (France)

^j BEAUJON HOSPITAL   (France)

^k HÔPITAL PELLEGRIN   (France)

^l EDOUARD HERRIOT HOSPITAL   (France)

^m HÔPITAL SAINT ANTOINE   (France)

ⁿ Roche Pharma   (France)

^o PONTCHAILLOU UNIVERSITY HOSPITAL   (France)

^p HÔPITAL PAUL BROUSSE   (France)

more..

Author keywords

Erythropoietin; Fibrosis; Hepatitis C virus; Peginterferon; Ribavirin; Viral response

Indexed keywords

CYCLOSPORIN A; ERYTHROPOIETIN; GRANULOCYTE COLONY STIMULATING FACTOR; MYCOPHENOLIC ACID; PEGINTERFERON ALPHA2A; PLACEBO; RIBAVIRIN; STEROID; TACROLIMUS;

ACUTE GRAFT REJECTION; ACUTE KIDNEY FAILURE; ADULT; AGED; ANTIVIRAL THERAPY; ANXIETY; ARTICLE; ASTHENIA; BODY WEIGHT; CONTROLLED STUDY; CYTOPENIA; DEPRESSION; DIABETES MELLITUS; DRUG WITHDRAWAL; FEMALE; GENOTYPE; GRAFT RECIPIENT; HEPATITIS C; HEPATITIS C VIRUS; HISTOPATHOLOGY; HUMAN; ISCHEMIC HEART DISEASE; KIDNEY FUNCTION; LIVER; LIVER BIOPSY; LIVER FIBROSIS; LIVER TRANSPLANTATION; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; MONOTHERAPY; MULTICENTER STUDY; NEUTROPHIL COUNT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECURRENT INFECTION; SIDE EFFECT; THROMBOCYTE COUNT; TREATMENT DURATION; TREATMENT RESPONSE; VIRUS LOAD;

ANTIVIRAL AGENTS; CYCLOSPORINE; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; FEMALE; GENOTYPE; HEPACIVIRUS; HEPATITIS C; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INDUCTION CHEMOTHERAPY; INTERFERON-ALPHA; KIDNEY; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; LOGISTIC MODELS; MAINTENANCE CHEMOTHERAPY; MALE; MIDDLE AGED; PLACEBOS; POLYETHYLENE GLYCOLS; RECOMBINANT PROTEINS; RECURRENCE; RIBAVIRIN; TACROLIMUS; TREATMENT OUTCOME; VIRAL LOAD;

EID: 84865109121     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2012.04.022     Document Type: Article

References (31)

1. L.M. Forman, J.D. Lewis, and J.A. Berlin The association between hepatitis C infection and survival after orthotopic liver transplantation Gastroenterology 122 2002 889 896 (Pubitemid 34267271)
2. M. Berenguer, M. Prieto, F. San Juan, J.M. Rayon, F. Martinez, and D. Carrasco Contribution of donor age to the recent decrease in patient survival among HCV-infected liver transplant recipients Hepatology 36 2002 202 210 (Pubitemid 34700779)
3. U.P. Neumann, T. Berg, M. Bahra, D. Seehofer, J.M. Langrehr, and R. Neuhaus Long-term outcome of liver transplants for chronic hepatitis C: a 10-year follow-up Transplantation 77 2004 226 231 (Pubitemid 38155751)
4. C. Feray, L. Caccamo, and G.J. Alexander European collaborative study on factors influencing outcome after liver transplantation for hepatitis C. European Concerted Action on Viral Hepatitis (EUROHEP) Group Gastroenterology 117 1999 619 625 (Pubitemid 29409247)
5. R.J. Firpi, M.F. Abdelmalek, C. Soldevila-Pico, R. Cabrera, J.J. Shuster, and D. Theriaque One-year protocol liver biopsy can stratify fibrosis progression in liver transplant recipients with recurrent hepatitis C infection Liver Transpl 10 2004 1240 1247 (Pubitemid 39406077)
6. E.J. Gane, S.K. Lo, and S.M. Riordan A randomized study comparing ribavirin and interferon alfa monotherapy for hepatitis C recurrence after liver transplantation Hepatology 27 1998 1403 1407 (Pubitemid 28227870)
7. N. Chalasani, C. Manzarbeitia, and P. Ferenci Peginterferon alfa-2a for hepatitis C after liver transplantation: two randomized, controlled trials Hepatology 41 2005 289 298 (Pubitemid 40165372)
8. D. Samuel, T. Bizollon, and C. Feray Interferon-alpha 2b plus ribavirin in patients with chronic hepatitis C after liver transplantation: a randomized study Gastroenterology 124 2003 642 650 (Pubitemid 36268483)
9. A.S. Ross, A.K. Bhan, M. Pascual, M. Thiim, A. Benedict Cosimi, and R.T. Chung Pegylated interferon alfa-2b plus ribavirin in the treatment of post-liver transplant recurrent hepatitis C Clin Transplant 18 2004 166 173 (Pubitemid 38404647)
10. J. Dumortier, J.Y. Scoazec, P. Chevallier, and O. Boillot Treatment of recurrent hepatitis C after liver transplantation: a pilot study of peginterferon alfa 2b and ribavirin combination J Hepatol 40 2004 669 674 (Pubitemid 38367790)
11. H. Rodríguez-Luna, A. Khatib, P. Sharma, G. De Petris, J.W. Williams, and J. Ortiz Treatment of recurrent hepatitis C infection after liver transplantation with combination of pegylated interferon alfa 2b and ribavirin: an open label series Transplantation 77 2004 190 194 (Pubitemid 38155744)
12. G.W. Neff, C.B. O'Brien, R. Cirocco, M. Montalbano, M. de Medina, and P. Ruiz Prediction of sustained virological response in liver transplant recipients with recurrent hepatitis C virus following combination pegylated interferon alfa2b and ribavirin therapy using tissue hepatitis C virus reverse transcriptase polymerase chain reaction testing Liver Transpl 10 2004 595 598 (Pubitemid 38628219)
13. M. Berenguer, A. Palau, V. Aguilera, J.M. Rayón, F.S. Juan, and M. Prieto Clinical benefits of antiviral therapy in patients with recurrent hepatitis C following liver transplantation Am J Transplant 8 2008 679 687 (Pubitemid 351287553)
14. B. Roche, M. Sebagh, M.L. Canfora, T. Antonini, A.M. Roque-Afonso, and V. Delvart Hepatitis C virus therapy in liver transplant recipients: response predictors, effect on fibrosis progression, and importance of the initial stage of fibrosis Liver Transpl 14 2008 1766 1777
15. J.A. Carrión, M. Navasa, M. García-Retortillo, J.C. García-Pagan, G. Crespo, and M. Bruguera Efficacy of antiviral therapy on hepatitis C recurrence after liver transplantation: a randomized controlled study Gastroenterology 132 2007 1746 1756 (Pubitemid 46695723)
16. B. Dousset, F. Conti, and D. Houssin Acute vanishing bile duct syndrome after interferon therapy for recurrent HCV infection in liver-transplant recipients N Engl J Med 330 1994 1160 1161 (Pubitemid 24118283)
17. S. Saab, D. Kalmaz, N.A. Gajjar, J. Hiatt, F. Durazo, and S. Han Outcomes of acute rejection after interferon therapy in liver transplant recipients Liver Transpl 10 2004 859 867 (Pubitemid 38979255)
18. J. Brok, L.L. Gluud, and C. Gluud Ribavirin monotherapy for chronic hepatitis C Cochrane Database Syst Rev 2005 CD005527
19. H. Fontaine, A. Vallet-Pichard, C. Equi-Andrade, B. Nalpas, V. Verkarre, and M.L. Chaix Histopathologic efficacy of ribavirin monotherapy in kidney allograft recipients with chronic hepatitis C Transplantation 78 2004 853 857 (Pubitemid 39298528)
20. T. Bizollon, U. Palazzo, C. Ducerf, M. Chevallier, M. Elliott, and J. Baulieux Pilot study of the combination of interferon alfa and ribavirin as therapy of recurrent hepatitis C after liver transplantation Hepatology 26 1997 500 504 (Pubitemid 27328333)
21. R. Quadri, E. Giostra, T. Roskams, J.M. Pawlotsky, G. Mentha, and L. Rubbia-Brandt Immunological and virological effects of ribavirin in hepatitis C after liver transplantation Transplantation 73 2002 373 378 (Pubitemid 34174286)
22. A.J. Demetris, K.P. Batts, A.P. Dhillon, L. Ferrell, J. Fung, and S.A. Geller Banff schema for grading liver allograft rejection: an international consensus document Hepatology 25 1997 658 663 (Pubitemid 27106450)
23. P. Bedossa, and T. Poynard An algorithm for the grading of activity in chronic hepatitis C: The METAVIR Cooperative Study Group Hepatology 24 1996 289 293 (Pubitemid 26260021)
24. R. Nagayama, A. Tanaka, H. Ankoh, T. Narita, M. Izumi, and K. Miyake Efficacy of ribavirin monotherapy following combination therapy with interferon alfa-2b and ribavirin for patients with chronic hepatitis C Hepatol Res 32 2005 101 106 (Pubitemid 40945769)
25. N. Kamar, J. Izopet, L. Alric, and L. Rostaing Lack of evidence for ribavirin monotherapy efficacy on liver fibrosis in hepatitis C virus positive renal transplant patients Transplantation 79 2005 1770 1771 (Pubitemid 40885285)
26. E. Oton, R. Barcena, J.M. Moreno-Planas, V. Cuervas-Mons, A. Moreno-Zamora, and C. Barrios Hepatitis C recurrence after liver transplantation: Viral and histologic response to full-dose PEG-interferon and ribavirin Am J Transplant 6 2006 2348 2355 (Pubitemid 44359420)
27. M. Berenguer, A. Palau, A. Fernandez, S. Benlloch, V. Aguilera, and M. Prieto Efficacy, predictors of response, and potential risks associated with antiviral therapy in liver transplant recipients with recurrent hepatitis C Liver Transpl 12 2006 1067 1076 (Pubitemid 44063780)
28. T. Bizollon, S.N. Ahmed, S. Radenne, M. Chevallier, P. Chevallier, and P. Parvaz Long term histological improvement and clearance of intrahepatic hepatitis C virus RNA following sustained response to interferon-ribavirin combination therapy in liver transplanted patients with hepatitis C virus recurrence Gut 52 2003 283 287 (Pubitemid 36115073)
29. M.F. Abdelmalek, R.J. Firpi, C. Soldevila-Pico, A.I. Reed, A.W. Hemming, and C. Liu Sustained viral response to interferon and ribavirin in liver transplant recipients with recurrent hepatitis C Liver Transpl 10 2004 199 207 (Pubitemid 38240118)
30. K. Watashi, M. Hijikata, M. Hosaka, M. Yamagi, and K. Shimotohno Cyclosporin A suppresses replication of hepatitis C virus genome in cultured hepatocytes Hepatology 38 2003 1282 1288 (Pubitemid 37314838)
31. M. Berenguer, V. Aguilera, F. San Juan, S. Benlloch, A. Rubin, and R. López-Andujar Effect of calcineurin inhibitors in the outcome of liver transplantation in hepatitis C virus-positive recipients Transplantation 90 2010 1204 1209